Dr. John Luo, MD

Dr. Luo practices at UCI Health - Orange in Orange, California, part of UC Irvine.

Dr. Luo's NPI, 1093748535, was assigned on July 8, 2006. Dr. Luo graduated from UTMB Health in 1994. Dr. Luo's California license number on file is A55398.

Dr. Luo's primary practice is UCI Health - Orange, at 101 City Drive South, Orange, CA 92868 in Orange County. The practice phone is (714) 456-7890.

Dr. Luo's primary practice is UCI Health - Orange in Orange, California, part of UC Irvine. The medical group on file is UCI Department of Psychiatry & Human Behavior. Dmand AI also links Dr. Luo to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Luo practices, 2 sites in all. Vendor and product names are available with a free account.

Psychiatry is Dr. Luo's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Luo is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dr. Luo has a license on file in California.

Dmand AI lists ADHD, adjustment disease, alcohol use disorders, anxiety, bipolar disorder, depression, insomnia and non-alzheimer's dementia (chronic) among the conditions Dr. Luo treats.

CMS data shows 377 Medicare services from Dr. Luo across 5 procedure codes in 2024, for 213 Medicare patients. Medicare paid $33,405 for them.

CMS counts 213 Medicare patients who saw Dr. Luo in 2024. The largest group is under 65, with 92 patients. 75% of them have mood disorders, and 74% have anxiety. 62% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Luo's median patient age at 41, with 43% women.

In 2024, Dr. Luo wrote 97 Medicare Part D claims for 20 patients. 91% of them were for generic drugs. CMS names the drug for 28 of them, across 1 drug with 11 or more claims each, at $671 in total drug cost. In 2023, CMS named 24 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Luo for performance year 2024, reported through an alternative payment model (APM). Dr. Luo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Luo as offering telehealth.

Dmand AI links 36 papers to Dr. Luo, published from 2011 to 2020. The most frequent topics are Psychiatry, Education, Medical, Continuing and Equipment Design. Dr. Luo has published most often in Acad Psychiatry. Dr. Luo's most frequent co-authors are Donald M. Hilty, MBA, MD, Robert J. Boland, MD and Steven Richard Chan, MD.

Dmand AI links Dr. Luo to 1 clinical trial. Conditions studied include Psychotic Disorders and Schizophrenia.

CMS Open Payments shows 12 general payments to Dr. Luo from 3 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 95% of the total. Otsuka Pharmaceutical Development & Commercialization, Inc. paid the most, $7,151.

Dmand AI lists 16 awards for Dr. Luo, most recently Fellow in 2015.

Dr. Luo graduated from UTMB Health in 1994. Dr. Luo is a member of APA.

Dr. Luo is in network with 8 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.